Ranbaxy Inc. clinical trials
Acquired by Sun Pharmaceutical Industries Limited, Mar 24, 2015 · source ↗
The registry lists 2 studies whose lead sponsor is Ranbaxy Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 15, 2012.
Before and after it joined Sun Pharmaceutical Industries Limited
- First submitted before Ranbaxy Inc. became part of Sun Pharmaceutical Industries Limited
- 2
- First submitted after Ranbaxy Inc. became part of Sun Pharmaceutical Industries Limited
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Ranbaxy Inc.2 studies
Something wrong with this grouping? Tell us on the Sun Pharmaceutical Industries Limited page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Sun Pharmaceutical Industries Limited studies →
- Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets Under Fasting ConditionsCompletedNCT01665222Phase 1
Sponsor listed in the registry: Ranbaxy Inc. · First submitted before Ranbaxy Inc. became part of Sun Pharmaceutical Industries Limited
- Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets Under Fed ConditionsCompletedNCT01665209Phase 1
Sponsor listed in the registry: Ranbaxy Inc. · First submitted before Ranbaxy Inc. became part of Sun Pharmaceutical Industries Limited